Yale is a designated Center of Excellence that seeks to render the highest quality care to acutely presenting and chronically ill Wilson disease patients. Care is provided by a core multidisciplinary team of physicians that includes hepatologists (adult and pediatric), neurologists (movement disorder specialists), dieticians, psychiatrists, transplant surgeons and other specialists at our Center that provide care and advice for Wilson disease patients. The center's committed health care professionals have expertise in the diagnosis and treatment of Wilson disease.

Yale is one of only a few sites worldwide participating in a new clinical trial for the treatment of Wilson disease with a new form of the chelating agent tetrathiomolybdate. Yale has enrolled and treated the first two patients in this protocol.

[ Ссылка ]
[ Ссылка ]

свернуть